SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Chevron Corp. engages in the provision of oil and gas energy solutions. It provides crude oil and natural gas, manufactures transportation fuels, lubricants, petrochemicals, and additives, and develops technologies that enhance business and the industry. It operates through the Upstream and Downstream segments. The Upstream segment consists of the exploration, development, and production of crude oil and natural gas, the liquefaction, transportation, and regasification associated with liquefied natural gas, the transporting of crude oil by major international oil export pipelines, the processing, transporting, storage, and marketing of natural gas, and a gas-to-liquids plant. The Downstream segment consists of the refining of crude oil into petroleum products, the marketing of crude oil and refined products, the transporting of crude oil and refined products by pipeline, marine vessel, motor equipment, and rail car, and the manufacturing and marketing of commodity petrochemicals and plastics for industrial uses and fuel & lubricant additives. The company was founded on September 10, 1879 and is headquartered in Houston, TX.

Chevron Corp.

Chevron (CVX) is trending as escalating geopolitical tensions in the Middle East, particularly around potential Strait of Hormuz disruptions and U.S./Israel strikes on Iran, are fueling a risk premium in oil prices. The community is actively discussing significant upside potential for energy stocks amid these supply fears and recent strategic movements by Chevron in Iraq and Venezuela, though some express caution regarding short-term volatility.

Trump For President

Intense public discourse surrounding Donald Trump's alleged connections to the Epstein files and recent geopolitical developments, alongside the performance of Trump-linked assets, are driving the trend for TRUMP crypto. This fuels a polarized community, with supporters hailing it as a "YUUUGE opportunity" while detractors widely condemn it as a "scam" or "pump and dump."

Fefe is a memecoin inspired by Matt Furie's book "Mindviscosity," published in 2020.  Follow FEFE, the alter ego of PEPE in the book “Mindviscosity” by Matt Furie.  Fefe is a main character in the book, who is a laid back and carefree frog living in a whimsical world. Fefe's relaxed and adventurous spirit captures the heart of this imaginative universe.  Launched stealth with no presale, zero taxes, LP burnt and contract renounced - TAX: 0/0 This narrative has its roots in a fascinating story.  Join us and become part of the $FEFE community today!

Fefe

FEFE CRYPTO is trending due to its robust community and compelling narrative as the "third frog" in Matt Furie's universe, positioning it as a significant play within the broader frog memecoin ecosystem. Community members are actively highlighting its strong market correlation and resilient performance.

Okta, Inc. engages in the provision of an identity management platform for enterprises. It operates through the United States and International geographical segments. The firm's products include single sign-on, multi-factor authentication, access gateway, API access management, authentication, adaptive MFA and lifecycle management. The company was founded by Todd McKinnon and J. Frederic Kerrest in 2009 and is headquartered in San Francisco, CA.

Okta Inc - Ordinary Shares - Class A

Okta Inc

Okta is experiencing volatility as the cybersecurity sector reacts to concerns that new AI tools could disrupt business models, prompting a "sell first, ask later" approach from some investors. However, community discussion highlights Okta's recent earnings beat and its strong positioning to capitalize on the growing demand for identity security in the AI agent landscape, further supported by a significant share buyback program.

NextEra Energy, Inc. engages in the provision of renewable energy. It operates through the following segments: FPL and NEER. The FPL segment involves the generation, transmission, distribution, and sale of electric energy in Florida. The NEER segment produces electricity from clean and renewable sources, including wind and solar. The company was founded on December 28, 1925 and is headquartered in Juno Beach, FL.

NextEra Energy Inc

NextEra Energy is trending following news of a $2 billion equity offering, which has introduced dilution concerns and prompted a price pullback. Despite this, community conversation remains focused on NEE's strategic role in powering the growing demand from AI data centers through partnerships with tech giants like Google and Meta.

Shell Plc engages in the business of producing oil and natural gas. It operates through the following segments: Integrated Gas, Upstream, Marketing, Chemicals and Products, Renewables and Energy Solutions, and Corporate. The Integrated Gas segment includes liquefied natural gas, and conversion of natural gas into gas-to-liquids fuels. The Upstream segment focuses on exploration and extraction of crude oil, natural gas, and natural gas liquids. The Marketing segment is involved in mobility, lubricants, and sectors and decarbonization businesses. The Chemicals and Products segment consists of chemicals manufacturing plants with marketing network and refineries, which turn crude oil and other feedstocks into a range of oil products. The Renewables and Energy Solutions segment provides renewable power generation, marketing, trading, and optimizing power and pipeline gas, as well as carbon credits and digitally enabled customer solutions. The Corporate segment covers non-operating activities supporting Shell such as holdings, treasury organization, self-insurance activities, and headquarters and central functions. The company was founded in February 1907 and is headquartered in London, the United Kingdom.

Shell Plc - ADR (Representing - Ordinary Shares)

Shell is trending due to widespread speculation surrounding a potential acquisition of BP, which was swiftly denied but fueled significant community discussion, alongside ongoing legal disputes over LNG contracts. The market is also focused on Shell's consistent share buyback programs and its leading position in the LNG sector amidst broader energy market volatility and geopolitical developments.

Occidental Petroleum Corp. engages in the exploration and production of oil and natural gas. It operates through the following segments: Oil and Gas, Chemical, and Midstream and Marketing. The Oil and Gas segment explores for, develops and produces oil and condensate, natural gas liquids, and natural gas. The Chemical segment manufactures and markets basic chemicals and vinyls. The Midstream and Marketing segment purchases, markets, gathers, processes, transports and stores oil, condensate, natural gas liquids, natural gas, carbon dioxide, and power. The company was founded in 1920 and is headquartered in Houston, TX.

Occidental Petroleum Corp.

Occidental Petroleum is capturing significant market attention due to escalating geopolitical tensions involving the Middle East and Venezuela, sparking widespread community discussion about a potential oil price surge. This sentiment is further bolstered by the company's recent strong Q4 earnings beat, dividend increase, and strategic debt reduction.

Diamondback Energy, Inc. is an independent oil and natural gas company, which engages in the acquisition, development, exploration, and exploitation of unconventional, onshore oil, and natural gas reserves. It operates through the Upstream and Midstream Services segments. The Upstream segment focuses on the Permian Basin operations in West Texas. The Midstream Services segment is involved in the Midland and Delaware Basins. The company was founded in December 2007 and is headquartered in Midland, TX.

Diamondback Energy Inc

Diamondback Energy is trending as investors digest its Q4 earnings, which featured a dividend increase and strategic asset divestitures aimed at debt reduction and capital efficiency, sparking mixed reactions on its valuation. The community is also closely watching FANG's Permian Basin operations in the broader context of fluctuating crude oil prices driven by geopolitical tensions and discussions around peak U.S. onshore production.

Codatta

XNY (Codatta) is trending due to its perceived strong performance and resilience against broader crypto market downturns, leading to community speculation about its potential for new highs driven by its AI/data utility and upcoming on-chain fingerprint verification feature.

Direxion Shares ETF Trust - Direxion Daily S&P Oil & Gas Exp. & Prod. Bull 2X Shares

Direxion Daily S&P Oil & Gas Exp. & Prod. Bull 2X Shares

Direxion Daily S&P Oil & Gas Exp. & Prod. Bull 2X Shares (GUSH) is trending as escalating Middle East tensions fuel community speculation on imminent oil supply disruptions, leading to significant call option activity and widespread expectations for a powerful rally across the leveraged energy sector.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Cartesian Therapeutics, Inc. (NASDAQ:RNAC) Given Average Recommendation of "Moderate Buy" by Analysts

Shares of Cartesian Therapeutics, Inc. (NASDAQ:RNAC - Get Free Report) have been given an average rating of "Moderate Buy" by the five ratings firms that are currently covering the firm...

Cartesian Therapeutics, Inc. (RNAC) Upgraded to Buy: What Does It Mean for the Stock?

Cartesian Therapeutics, Inc. (RNAC) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Cartesian Therapeutics, Inc. (NASDAQ:RNAC) Receives Consensus Recommendation of "Moderate Buy" from Analysts

Shares of Cartesian Therapeutics, Inc. (NASDAQ:RNAC - Get Free Report) have been given an average recommendation of "Moderate Buy" by the five research firms that are currently covering the firm...

Cartesian Therapeutics, Inc. (NASDAQ:RNAC) Receives Consensus Recommendation of "Moderate Buy" from Brokerages

Shares of Cartesian Therapeutics, Inc. (NASDAQ:RNAC - Get Free Report) have received an average recommendation of "Moderate Buy" from the six brokerages that are presently covering the firm...

What is HC Wainwright's Estimate for RNAC FY2025 Earnings?

Cartesian Therapeutics, Inc. (NASDAQ:RNAC - Free Report) - Investment analysts at HC Wainwright cut their FY2025 earnings per share estimates for Cartesian Therapeutics in a research note issued on...

HC Wainwright Issues Pessimistic Forecast for Cartesian Therapeutics (NASDAQ:RNAC) Stock Price

HC Wainwright cut their price target on Cartesian Therapeutics from $40.00 to $30.00 and set a "buy" rating for the company in a report on Wednesday...

Cartesian Therapeutics (NASDAQ:RNAC) Given New $44.00 Price Target at BTIG Research

BTIG Research increased their price objective on Cartesian Therapeutics from $42.00 to $44.00 and gave the company a "buy" rating in a research note on Friday...

Cartesian Pauses Lupus And Multiple Myeloma Studies As It Shifts Development Focus

Cartesian Therapeutics shared initial data from Phase 2 trial of Descartes-08, showing potential for treating systemic lupus erythematosus.read more...

Cantor Fitzgerald Issues Negative Estimate for RNAC Earnings

Cartesian Therapeutics, Inc. (NASDAQ:RNAC - Free Report) - Stock analysts at Cantor Fitzgerald decreased their FY2025 earnings estimates for Cartesian Therapeutics in a research report issued to...

Wedbush Has Negative Forecast for RNAC FY2025 Earnings

Cartesian Therapeutics, Inc. (NASDAQ:RNAC - Free Report) - Research analysts at Wedbush cut their FY2025 earnings estimates for shares of Cartesian Therapeutics in a note issued to investors on...

Cartesian Therapeutics, Inc. operates as a clinical-stage biotechnology company. It provides mRNA cell therapies for the treatment of autoimmune diseases. It operates in research and development of cell therapy product candidates. The company is headquartered in Gaithersburg, MD.

Cartesian Therapeutics Inc

Day trading

Swing trading

Long-term investing

Sitting in cash

Markets have been volatile, with macro headlines and earnings driving sharp moves. How are you positioning right now?

Drop your approach below 👇

RNAC
Selecta Biosciences Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest RNAC News

RNACSelecta Biosciences Inc